CD274 and central nervous system cancer: Upon intracranial injection of RRV-scFc-PDL1 in glioma-bearing mice, approximately 50–150-fold less scFv-PD-L1 was detected in serum and survival was significantly improved (p = 0.0045) compared to systemic administration of PD-1 blocking antibody [94].